65222-35-7

65222-35-7 structure
65222-35-7 structure

Name Pazelliptine
Synonyms Pazeliptina [Spanish]
EINECS 265-640-7
N,N-diethyl-N'-(6-methyl-5H-pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinoline-10-yl)-propane-1,3-diamine
n,n-diethyl-n'-(6-methyl-5h-pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolin-10-yl)propane-1,3-diamine
10-<<3-(diethylamino)propyl>amino>-6-methyl-5H-pyrido<3',4':4,5>pyrrolo<2,3-g>isoquinoline
BD-40
Pazelliptinum [Latin]
Density 1.21g/cm3
Boiling Point 615.2ºC at 760 mmHg
Molecular Formula C22H27N5
Molecular Weight 361.48300
Flash Point 325.9ºC
Exact Mass 361.22700
PSA 56.84000
LogP 4.78950
Index of Refraction 1.707

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TX7388500
CAS REGISTRY NUMBER :
65222-35-7
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C22-H27-N5
MOLECULAR WEIGHT :
361.54

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent

MUTATION DATA

TYPE OF TEST :
DNA adduct
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
17 umol/L
REFERENCE :
BUCABS Bulletin du Cancer. (SPPIF, B.P.22, F-41353 Vineuil, France) V.53- 1966- Volume(issue)/page/year: 67,9,1980

~76%

65222-35-7 structure

65222-35-7

Literature: Sanofi Patent: US5079363 A1, 1992 ;

~87%

65222-35-7 structure

65222-35-7

Literature: Dormoy; Heymes Tetrahedron, 1993 , vol. 49, # 14 p. 2915 - 2938

~%

65222-35-7 structure

65222-35-7

Literature: Dormoy; Heymes Tetrahedron, 1993 , vol. 49, # 14 p. 2915 - 2938

~84%

65222-35-7 structure

65222-35-7

Literature: Dormoy; Heymes Tetrahedron, 1993 , vol. 49, # 14 p. 2915 - 2938
Precursor  3

DownStream  0